Impact of left ventricular ejection fraction and aortic valve gradient on mortality following transcatheter aortic valve intervention.
Ian C GilchristSmadar KortTing-Yu WangHenry TannousRobert PyoEly GraciaThomas BilfingerHal A SkopickiPuja B ParikhPublished in: Cardiovascular revascularization medicine : including molecular interventions (2024)
In this prospective, contemporary registry of adults undergoing TAVI, while 1-year unadjusted mortality rates are significantly higher in patients with reduced LVEF and reduced AVG, risk-adjusted mortality at 1 year is only higher in those with reduced AVG - not in those with reduced LVEF.
Keyphrases
- aortic valve
- aortic stenosis
- ejection fraction
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- aortic valve replacement
- left ventricular
- cardiovascular events
- risk factors
- randomized controlled trial
- coronary artery disease
- cardiovascular disease
- acute coronary syndrome
- hypertrophic cardiomyopathy
- atrial fibrillation